OCUGEN, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
OCUGEN, INC. (OCGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 84.40% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2019-03-22
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2018-09-30 was 86.40%, a 44.00% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2018-06-30 was 59.80%, a 0.66% decline year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2018-03-31 was 88.20%, a 35.07% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2017-09-30 was 60.00%, a 29.58% decline year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2018 was 84.40%, a 34.18% increase from fiscal 2017.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2017 was 62.90%, a 13.24% decline from fiscal 2016.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2016 was 72.50%, a 15.81% increase from fiscal 2015.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2015 was 62.60%, a 40.10% decline from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2018-12-31 | 84.40% 10-K · filed 2019-03-22 | |||
| 2018-09-30 | 86.40% 10-Q · filed 2018-11-08 | 87.50% 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | 59.80% 10-Q · filed 2018-08-09 | 83.10% 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | 88.20% 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | 62.90% 10-K · filed 2019-03-22 | |||
| 2017-09-30 | 60.00% 10-Q · filed 2018-11-08 | 63.10% 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | 60.20% 10-Q · filed 2018-08-09 | 63.20% 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | 65.30% 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | 72.50% 10-K · filed 2018-03-15 | |||
| 2016-09-30 | 85.20% 10-Q · filed 2017-11-09 | 59.70% 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | 65.80% 10-Q · filed 2017-08-10 | 59.60% 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | 59.60% 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | 62.60% 10-K · filed 2017-03-16 | |||
| 2015-09-30 | 60.10% 10-Q · filed 2016-11-10 | 62.80% 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | 59.60% 10-Q · filed 2016-08-11 | 64.30% 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | 65.80% 10-Q · filed 2016-05-12 | |||
| 2014-12-31 | 104.50% 10-K · filed 2016-03-10 | |||
| 2014-09-30 | 104.40% 10-Q · filed 2015-11-12 | 104.50% 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | 104.60% 10-Q · filed 2015-08-12 | 92.00% 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | 87.90% 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |